Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.

Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.

Item
http://www.wikidata.org/entity/Q50120819
Development and progress for three decades in umu test systemsContributions of human enzymes in carcinogen metabolismSummary of information on human CYP enzymes: human P450 metabolism data.Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP.Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung.Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus.Lack of Modifying Effects of Intratracheal Instillation of Quartz or Dextran Sulfate Sodium (DSS) in Drinking Water on Lung Tumor Development Initiated with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Female A/J Mice.Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.Applications of CYP-450 expression for biomonitoring in environmental healthA regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis.When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials.High Level of Tobacco Carcinogen-Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers.Variation in CYP2A6 Activity and Personalized Medicine.Detection of gentoxicity of benzidine and its derivatives with the Escherichia coli DJ 702 lacZ reversion mutagenicity assay.Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers.
P2860

Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.

Item
http://www.wikidata.org/entity/Q50120819
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@en
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@nl
type
label
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@en
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@nl
prefLabel
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@en
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Metabolic activation of N-alky ...... DPH-cytochrome P450 reductase.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698